These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9803250)

  • 21. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economics of blood screening: in search of an optimal blood screening strategy.
    Chinkhumba J
    Trop Doct; 2006 Jan; 36(1):32-4. PubMed ID: 16483429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method.
    Konomi N; Yamaguchi M; Naito H; Aiba N; Saito T; Arakawa Y; Abe K
    Jpn J Infect Dis; 2000 Apr; 53(2):70-2. PubMed ID: 10871918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis G in patients on chronic hemodialysis.
    Matzkies FK; Bahner U; Weizenegger M; Bartel J; Cullen P; Schaefer RM
    Clin Lab; 2000; 46(5-6):247-50. PubMed ID: 10853231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nearing the end of post-transfusional hepatitis?].
    Hernández JM; González A
    Sangre (Barc); 1990 Jun; 35(3):169-71. PubMed ID: 2396163
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis G virus.
    Dasarathy S
    Trop Gastroenterol; 1997; 18(1):1-2. PubMed ID: 9197162
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis G virus or hepatitis GB virus C].
    Heinsen A; Fomsgaard A
    Ugeskr Laeger; 1999 May; 161(18):2653-6. PubMed ID: 10434784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GB virus C infection by blood transfusion during and following liver surgery.
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Kinoshita H; Kuroki T
    Hepatogastroenterology; 1998; 45(24):2252-4. PubMed ID: 9951905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors.
    Halasz R; Sällberg M; Lundholm S; Andersson G; Lager B; Glaumann H; Weiland O
    J Infect Dis; 2000 Dec; 182(6):1756-60. PubMed ID: 11069249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing trend of hyperbilirubinemia incidence in the blood donors population.
    Pintera J
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(4):343-8. PubMed ID: 2100746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Routines ordered by law for testing of potential disease transmission are not sufficient].
    Andersen BM
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):252-3. PubMed ID: 10081361
    [No Abstract]   [Full Text] [Related]  

  • 39. Infection with GB virus C/hepatitis G virus among blood donors and hemophiliacs in Martinique, a Caribbean island.
    Césaire R; Martial J; Maier H; Kerob-Bauchet B; Bera O; Duchaud E; Brebion A; Pierre-Louis S
    J Med Virol; 1999 Oct; 59(2):160-3. PubMed ID: 10459150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis testing.
    Bianco C
    Immunol Invest; 1995; 24(1-2):155-61. PubMed ID: 7713579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.